1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. Maryland >
  6. Elanco Acquires Chemgen

M&A Deal Summary

Elanco Acquires Chemgen

On January 24, 2012, Elanco acquired life science company Chemgen

Acquisition Highlights
  • This is Elanco’s 2nd transaction in the Life Science sector.
  • This is Elanco’s 3rd transaction in the United States.
  • This is Elanco’s 1st transaction in Maryland.

M&A Deal Summary
Date 2012-01-24
Target Chemgen
Sector Life Science
Buyer(s) Elanco
Deal Type Add-on Acquisition
Advisor(s) Houlihan Lokey (Financial)

Target

Chemgen

Gaithersburg, Maryland, United States
ChemGen Corp. is a bioscience company specializing in the development and commercialization of innovative feed enzyme products that improve the efficiency of poultry, egg, and meat production.

Search 205,240 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Elanco

Greenfield, Indiana, United States
Category Company
Founded 1954
Sector Life Science
Employees9,300
Revenue 4.4B USD (2023)
DESCRIPTION

Elanco develops and markets products and services to improve animal health and protein production in more than 75 countries. Elanco employs more than 3,000 people worldwide, with offices in more than 40 countries. Elanco was incorporated in 1954 and is based in Greenfield, Indiana.

DEAL STATS #
Overall 4 of 11
Sector (Life Science) 2 of 7
Type (Add-on Acquisition) 1 of 6
State (Maryland) 1 of 1
Country (United States) 3 of 6
Year (2012) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2011-03-14 Janssen Pharmaceuticals - Animal Health Business

Beerse, Belgium

Janssen Pharmaceuticals - Animal Health Business is primarily European-focused, targeting disease segments in companion animals and livestock, with special emphasis on swine and poultry.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-02-24 Lohman SE

Cuxhaven, Germany

Lohmann is a manufacturer of feed additives and poultry vaccines, selling its products in over 80 countries around the world. Headquartered in Cuxhaven, Germany, Lohmann has a production facility there, a vaccine plant in Winslow, Maine, and is represented by 18 subsidiaries in Europe, Asia and North America. The focus of Lohmann is the development of vaccines and food components that help prevent diseases of animals used in food production.

Buy -
Mergr

Product

Company

Legal